Navigation Links
Reportlinker Adds Market Opportunities for Supergenerics

NEW YORK, Dec. 21, 2010 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Market Opportunities for Supergenerics

The negative economic climate has meant that governments and payors alike are looking at reducing the prices of drugs as one way to contain costs. This has particularly affected areas where there is strong competition as with commodity generics. This report assesses the potential of new supergenerics in the setting of specific therapeutic classes. The report identifies the drivers and resistors for developing supergenerics in different countries and regions, and evaluates regulatory issues that hamper or encourage the development of supergenerics. It also evaluates the different company types that are involved in the supergeneric sector.

Scope of this research

  • Assess the competitive environment for supergenerics.
  • Evaluate the pros and cons in adopting a supergeneric strategy and see how your company might take steps to improve its skills and know-how.
  • Identify strategies and therapy areas most likely to be successful in the supergenerics area.
  • Understand the situation in terms of competing technologies in the development of supergenerics and which ones are more advanced in development.
  • Identify technologies which may be useful in developing supergenerics.

  • Research and analysis Highlights The report identifies that there is still considerable scope for gaining price premiums for supergenerics in most areas studied. Although price premiums are obtainable in free price setting markets like the US the situation in the EU is complicated and reimbursement levels may pose another hurdle for SG producers in the diverse EU market place.

    SG producers have been forced to focus on areas of unmet medical need and high sales potential markets such as the CNS area, as innovative companies have already patented widely and developed many line extensions in more obvious and easy to formulate areas such as cardiovascular, with single isomers, combinations, extended release, and prodrugs.

    There are considerable opportunities for licensing products for wider markets as often SG producers concentrate on just one market and require licensing partners to reach other geographic areas and will usually have no access to emerging markets which offer potential for SG sales.

    Key reasons to purchase this research

  • Where are the most successful supergenerics markets?
  • What effect are government policies having on the supergenerics sector?
  • What technologies are offering important advances in certain therapy areas?
  • Are supergenerics patents more susceptible to generic challenges than NCE patents?
  • Which companies have been successful in developing supergenerics and will this success continue?

  • To order this report:: Market Opportunities for Supergenerics

    More  Market Research Report

    Check our  Company Profile, SWOT and Revenue Analysis!CONTACT:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Reportlinker Adds US Disposable Medical Supplies Market Report
    2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
    3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
    4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
    5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
    6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
    7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
    8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
    9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
    10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
    11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
    Post Your Comments:
    (Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
    (Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
    (Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
    Breaking Medicine Technology:
    (Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
    (Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
    (Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
    (Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
    (Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
    Breaking Medicine News(10 mins):